GlassScriptPhysician profile
Cornel C Van Gorp
NPI 1255317475
$612.37
in general payments reported to CMS, 2019-2025
10 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.79 · 2023: $73.04 · 2024: $263 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $193.30 | 2024-2025 | Mako, Regenkit-Tht |
| Zimmer Biomet Holdings, INC. | $169.09 | 2019-2024 | Persona, Tapestry |
| Linvatec Corporation | $126.05 | 2025 | Biobrace 23mm |
| Xtant Medical INC | $24.65 | 2023 | |
| Innovation Technologies INC | $21.60 | 2025 | Irrisept |
| Smith+Nephew, INC. | $21.25 | 2025 | Redapt |
| Merck Sharp & Dohme LLC | $16.22 | 2023 | Keytruda |
| Boston Scientific Corporation | $14.27 | 2023 | |
| Acumed LLC | $13.81 | 2025 | Innate Implant, Acumed |
| Amgen INC. | $12.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornel Van Gorp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.